Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-07-000478
Filing Date
2007-02-09
Accepted
2007-02-09 12:31:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 osipharmaceuticalsinc1.txt SC 13G/A 10633
  Complete submission text file 0000769993-07-000478.txt   12426
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Subject) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-37954 | Film No.: 07596585
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address
Business Address 32 OLD SLIP NEW YORK NY 10005
GOLDMAN SACHS ASSET MANAGEMENT LP (Filed by) CIK: 0001229262 (see all company filings)

EIN.: 000000000
Type: SC 13G/A